Dalbavancin for the treatment of acute bacterial skin and skin structure infections

INTRODUCTION: Acute bacterial skin and skin structure infections (ABSSSI) have increased in incidence and severity. The involvement of resistant organisms, particularly methicillin-resistant Staphylococcus aureus, presents additional challenges. The lipoglycopeptide dalbavancin has a prolonged half-...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Expert Opin Pharmacother
Egile Nagusiak: Ramdeen, Sheena, Boucher, Helen W
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4600683/
https://ncbi.nlm.nih.gov/pubmed/26239321
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak